Jayadeep “Jay” R. Deshmukh represents clients in complex intellectual property and patent infringement cases, with more than 20 years of experience advising on major Hatch-Waxman Act litigations. Many of his clients are international generic drug makers, who he counsels on product launches and defends against suits from brand-name manufacturers. Jay regularly serves as settlement and Food and Drug Administration (FDA) counsel for smaller generic pharmaceutical companies, advising on exclusivity matters against the Office of the Chief Counsel of the FDA.

Recognized by both The Legal 500 and LMG Life Sciences, Jay also has deep experience working with the Federal Trade Commission and advising companies who seek patent litigation counsel in the European Union (E.U.), where he defends clients in more than 10 E.U. jurisdictions.

Jay previously served as senior vice president of Global IP at Ranbaxy Laboratories, an international generic pharmaceutical company, where he was responsible for the creation of the company’s global intellectual property department.